APA (7th ed.) Citation

Wucherpfennig, L., Becker, J. K. Z., Wuennemann, F., Eichinger, M., Seitz, A., Baumann, I., . . . Wielpütz, M. O. (2024). Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor. Journal of cystic fibrosis, 23(2), . https://doi.org/10.1016/j.jcf.2024.01.004

Chicago Style (17th ed.) Citation

Wucherpfennig, Lena, et al. "Elexacaftor/tezacaftor/ivacaftor Improves Chronic Rhinosinusitis Detected by Magnetic Resonance Imaging in Children with Cystic Fibrosis on Long-term Therapy with Lumacaftor/ivacaftor." Journal of Cystic Fibrosis 23, no. 2 (2024). https://doi.org/10.1016/j.jcf.2024.01.004.

MLA (9th ed.) Citation

Wucherpfennig, Lena, et al. "Elexacaftor/tezacaftor/ivacaftor Improves Chronic Rhinosinusitis Detected by Magnetic Resonance Imaging in Children with Cystic Fibrosis on Long-term Therapy with Lumacaftor/ivacaftor." Journal of Cystic Fibrosis, vol. 23, no. 2, 2024, https://doi.org/10.1016/j.jcf.2024.01.004.